We use cookies for a better user experience. Read our Privacy Policy

I Agree

Life Science Reagents Market

Life Science Reagents Market (Product: Chromatography Reagents, Molecular Diagnostics Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, Flow Cytometry Reagents, Cell & Tissue Culture Reagents, Hematology & Hemostasis Reagents, Microbiology Reagents, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Life Science Reagents Market Outlook 2031

  • The global life science reagents market was valued at US$ 54.7 Bn in 2021
  • The global market is projected to grow at a CAGR of 5.7% from 2022 to 2031
  • The global life science reagents market is expected to reach more than US$ 100 Bn by the end of 2031

Analysts’ Viewpoint on Life Science Reagents Market Scenario

Life science reagents are an integral part of pharmaceutical, biotechnology, life science, and health care industries. The global life science reagents market is expected to witness strong growth during the forecast period due to the increase in application of life science reagents in in vitro diagnostics for the diagnosis of various chronic as well as infectious diseases. Life science reagents are also used to predict disease course, formulate treatment, and monitor the effectiveness of the therapy. Increase in pharmaceutical R&D budgets by governments and private players is likely to support the development of new products and technologies. This is projected to create lucrative revenue opportunities for manufacturers of life science reagents during the forecast period.

Life Science Reagents Market

Overview of Life Science Reagents Market

Life science reagents are substances or compounds used in a chemical reaction to observe and record changes. Medical researchers analyze this data to determine the cause of a disease. Life science and analytical reagents are used in chemical reactions to measure, detect, or examine other substances. Technological advancements in molecular biology, life sciences, and biotechnology have brought about significant changes in health care diagnostics, drug discovery, personalized medicines, forensic sciences, and clinical research & development. This has increased the demand for biotechnology media, sera and reagents, biotechnology reagents, etc. Growth of the life science industry and increase in incidence rate of chronic and infectious diseases are driving the global life science reagents market.

Request a sample to get extensive insights into the Life Science Reagents Market

Increase in Geriatric Population and Rise in Need for Disease Diagnosis Propel Global Life Science Reagents Market

Advances in the health care industry and life sciences industry, improvement in public health measures, and decrease in life-threatening infectious diseases in developed countries are augmenting the life expectancy of the global geriatric population. According to the United Nations, the elderly population (aged 60+ years) is expected to double by 2050 and triple by 2100. The population is likely to rise from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100. Globally, the geriatric population is growing at a faster rate than the young population. The geriatric population in Asia Pacific and South America is estimated to increase by 300% in the next decade. As part of preventive health care, the geriatric population and people with chronic diseases such as diabetes, respiratory disorders, and cancer regularly require medical tests such as blood tests and urine tests. This is projected to augment the life science reagents market during the forecast period.

Rise in Adoption of Advanced Products to Drive Global Life Science Reagents Market

Development in the areas of enzyme-linked immune assay technology (ELISA), polymerase chain reaction (PCR) such as digital PCR, rtPCR, chromatography, single cell technology, next-generation sequencing (NGS), and flow cytometry techniques; and their application in the health care industry in disease diagnostics and treatment monitoring are propelling the life science reagents market. For instance, the chemiluminescence immunoassay (CLIA) technology provides enhanced sensitivity, specificity, improved precision, and reduced incubation. Together, these increase the efficiency of the technology to diagnose different types of genetic, chronic, acute, and infectious diseases. Technological advancements in point-of-care (POC) instruments for the diagnosis of various chronic and infectious diseases within a short period, development of high throughput automated immunoassay analyzers, and integration of the various diagnostic techniques in a single system are factors fueling the demand for in vitro diagnostics reagents in the health care industry. Advances in genomics and proteomics have led to the development of newer genetic and protein biomarkers for the diagnosis of cancer and several genetic diseases. Genomic studies are also used in pharmacogenetics and targeted therapy to identify infectious diseases by sequencing reagents to diagnose genetic factors that contribute to common diseases and personalized medicines. Increase in application of cell and tissue culture for the production of monoclonal antibodies, drug development, vaccines, enzymes, growth hormones, and stem cell therapy is propelling the demand for life science reagents.

Request a custom report on Life Science Reagents Market

Growth in Prevalence of Chronic and Infectious Diseases to Augment Global Life Science Reagents Market

Diagnosis of infectious and chronic diseases is one of the leading applications of in vitro diagnostics. Life science reagents, both biological and laboratory chemical reagents, are integral part of any diagnostic test. Emergence and outbreak of various infectious diseases have created challenges and new opportunities for researchers to develop life science tools and reagents for early diagnosis and prevention of disease. As of June 2022, coronavirus (COVID-19) has caused 539 million confirmed infections and 6.3 million deaths. The pandemic does not show any sign of abatement. The impact and consequences of the COVID-19 pandemic positively impacted the life science reagents market in 2020 and 2021. Growth of the diagnostics segment, led by Covid-19 testing and continuous research & development conducted by various pharmaceutical & biotechnological companies to develop medicines and vaccines, is likely to drive the life science reagents market during the forecast period.

Popularity of Immunoassay as Diagnostic Tool to Drive Demand for Immunoassay Reagents

In terms of product, the global life science reagents market has been classified into chromatography reagents, molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, flow cytometry reagents, cell & tissue culture reagents, hematology & hemostasis reagents, microbiology reagents, and others. The immunoassay reagents segment dominated the global life science reagents market in 2021. The trend is projected to continue during the forecast period. Immunoassay is a highly preferred diagnostic technique used in hospitals and pathology laboratories. The immunoassay technique is increasingly becoming a popular diagnostic tool owing to specific results, high sensitivity, and ease of use.

High Usage of Life Science Reagents to Propel Hospitals & Diagnostics Laboratories Segment

Based on end-user, the global life science reagents market has been divided into hospitals & diagnostic laboratories, commercial & contract research manufacturers, academic & research institutes, and others. The hospitals & diagnostic laboratories segment dominated the global life science reagents market in 2021 due to the high usage of life science reagents in hospitals and laboratories for the diagnosis of Covid-19.

Regional Outlook of Global Life Science Reagents Market

North America accounted for the largest share of around 35% of the global life science reagents market in 2021. The market in the region is projected to grow at a CAGR of 5.5% from 2022 to 2031. The life science reagents market in Asia Pacific is anticipated to grow at a higher CAGR during the forecast period due to the large patient pool and rise in investment in health care in countries such as China and India.

Analysis of Key Players in Global Life Science Reagents Market

The global life science reagents market is fragmented, with the presence of a large number of key players. Most companies are making significant investments in research & development activities. Expansion of product portfolios and mergers & acquisitions are the key strategies adopted by the players. Key players operating in the market include F. Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation.

Key Developments in Global Life Science Reagents Market

  • In January 2022, Beckman Coulter Life Sciences announced that it received the EU Quality Management System Certificate under the new In Vitro Diagnostic Medical Devices Regulation (IVDR) for more than 200 flow cytometry reagents developed and manufactured at its Marseille, France, facility
  • In December 2021, Thermo Fisher Scientific, Inc. acquired PeproTech, Inc., a U.S.-based developer and manufacturer of recombinant proteins, for US$ 1.86 Bn in net cash. PeproTech provides bioscience reagents known as recombinant proteins, including cytokines and growth factors.
  • In January 2021, Thermo Fisher Scientific, Inc. acquired the Belgium-based European viral vector manufacturing business of Groupe Novasep SAS for US$ 830 Mn in net cash consideration. It provides manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers.

Each of these players has been profiled in the life science reagents market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Life Science Reagents Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 54.7 Bn

Market Forecast Value in 2031

More than US$ 100 Bn

Growth Rate

5.7%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

Market share analysis by company (2021)

Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product
    • Chromatography Reagents
    • Molecular Diagnostics Reagents
    • Immunoassay Reagents
    • Clinical Chemistry Reagents
    • Flow Cytometry Reagents
    • Cell & Tissue Culture Reagents
    • Hematology & Hemostasis Reagents
    • Microbiology Reagents
    • Others
  • End-user
    • Hospitals & Diagnostics Laboratories
    • Commercial & Contract Research Manufacturers
    • Academic & Research Institutes
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • Abbott
  • Siemens Healthineers
  • DiaSorin S.p.A
  • Sysmex Corporation
  • bioMerieux SA
  • Thermo Fisher Scientific, Inc.
  • BD
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Waters Corporation
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Life Science Reagents Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global life science reagents market in 2021?

The global life science reagents market was valued at US$ 54.7 Bn in 2021.

How big will be the global life science reagents market in 2031?

The global life science reagents market is projected to reach more than US$ 100 Bn by 2031.

What was the CAGR of the global life science reagents market from 2017–2021?

The global life science reagents market expanded at a CAGR of 11.3% from 2017 to 2021.

What will be the CAGR of the global life science reagents market during the forecast period (2022–2031)?

The global life science reagents market is anticipated to expand at a CAGR of 5.7% from 2022 to 2031.

Which are the prominent trends that affect market growth?

Rise in demand for testing & diagnosis due to increase in patient population with infectious and chronic diseases, surge in research & development, and availability of technologically advanced products drive the global market.

What was the market share of the leading segment of the global life science reagents market?

The dialysis products segment accounted for more than 30% share of the global life science reagents market in 2021.

Which region will account for the major share of the global market during the forecast period?

North America is expected to account for major share of the global life science reagents market during the forecast period.

Who are the prominent players in the global life science reagents market?

Prominent players in the global life science reagents market include F. Hoffmann-La Roche AG, Danaher Corporation, Abbott, Siemens Healthineers, DiaSorin S.p.A, Sysmex Corporation, bioMerieux SA, Thermo Fisher Scientific, Inc., BD, Merck KGaA, Agilent Technologies, Inc., and Waters Corporation.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Life Science Reagents Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Life Science Reagents Market Analysis and Forecast,

          2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Key Mergers & Acquisitions

    5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Life Science Reagents Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Chromatography Reagents

        6.3.2. Molecular Diagnostic Reagents

        6.3.3. Immunoassay Reagents

        6.3.4. Clinical Chemistry Reagents

        6.3.5. Flow Cytometry Reagents

        6.3.6. Cell & Tissue Culture Reagents

        6.3.7. Hematology & Hemostasis Reagents

        6.3.8. Microbiology Reagents

        6.3.9. Others

    6.4. Market Attractiveness Analysis, by Product

7. Global Life Science Reagents Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Hospitals & Diagnostics Laboratories

        7.3.2. Commercial & Contract Research Manufacturers

        7.3.3. Academic & Research Institutes

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Life Science Reagents Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Life Science Reagents Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Product, 2017–2031

        9.2.1. Chromatography Reagents

        9.2.2. Molecular Diagnostic Reagents

        9.2.3. Immunoassay Reagents

        9.2.4. Clinical Chemistry Reagents

        9.2.5. Flow Cytometry Reagents

        9.2.6. Cell & Tissue Culture Reagents

        9.2.7. Hematology & Hemostasis Reagents

        9.2.8. Microbiology Reagents

        9.2.9. Others

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals & Diagnostics Laboratories

        9.3.2. Commercial & Contract Research Manufacturers

        9.3.3. Academic & Research Institutes

        9.3.4. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. US

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Product

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Life Science Reagents Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Chromatography Reagents

        10.2.2. Molecular Diagnostic Reagents

        10.2.3. Immunoassay Reagents

        10.2.4. Clinical Chemistry Reagents

        10.2.5. Flow Cytometry Reagents

        10.2.6. Cell & Tissue Culture Reagents

        10.2.7. Hematology & Hemostasis Reagents

        10.2.8. Microbiology Reagents

        10.2.9. Others

    10.3. Market Value Forecast, by End-user, 2017–2031

        10.3.1. Hospitals & Diagnostics Laboratories

        10.3.2. Commercial & Contract Research Manufacturers

        10.3.3. Academic & Research Institutes

        10.3.4. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Italy

        10.4.5. Spain

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Product

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Life Science Reagents Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Chromatography Reagents

        11.2.2. Molecular Diagnostic Reagents

        11.2.3. Immunoassay Reagents

        11.2.4. Clinical Chemistry Reagents

        11.2.5. Flow Cytometry Reagents

        11.2.6. Cell & Tissue Culture Reagents

        11.2.7. Hematology & Hemostasis Reagents

        11.2.8. Microbiology Reagents

        11.2.9. Others

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. Hospitals & Diagnostics Laboratories

        11.3.2. Commercial & Contract Research Manufacturers

        11.3.3. Academic & Research Institutes

        11.3.4. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Product

        11.5.2. By End-user/p>

        11.5.3. By Country/Sub-region

12. Latin America Life Science Reagents Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Chromatography Reagents

        12.2.2. Molecular Diagnostic Reagents

        12.2.3. Immunoassay Reagents

        12.2.4. Clinical Chemistry Reagents

        12.2.5. Flow Cytometry Reagents

        12.2.6. Cell & Tissue Culture Reagents

        12.2.7. Hematology & Hemostasis Reagents

        12.2.8. Microbiology Reagents

        12.2.9. Others

    12.3. Market Value Forecast By End-user, 2017–2031

        12.3.1. Hospitals & Diagnostics Laboratories

        12.3.2. Commercial & Contract Research Manufacturers

        12.3.3. Academic & Research Institutes

        12.3.4. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Product

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa Life Science Reagents Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Chromatography Reagents

        13.2.2. Molecular Diagnostic Reagents

        13.2.3. Immunoassay Reagents

        13.2.4. Clinical Chemistry Reagents

        13.2.5. Flow Cytometry Reagents

        13.2.6. Cell & Tissue Culture Reagents

        13.2.7. Hematology & Hemostasis Reagents

        13.2.8. Microbiology Reagents

        13.2.9. Others

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. Hospitals & Diagnostics Laboratories

        13.3.2. Commercial & Contract Research Manufacturers

        13.3.3. Academic & Research Institutes

        13.3.4. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Product

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2021

    14.3. Company Profiles

        14.3.1. F. Hoffmann-La Roche AG

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. Financial Overview

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. Danaher Corporation

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. Financial Overview

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. Abbott

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. Financial Overview

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Siemens Healthineers

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. Financial Overview

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

        14.3.5. DiaSorin S.p.A

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Product Portfolio

            14.3.5.3. Financial Overview

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. Sysmex Corporation

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Product Portfolio

            14.3.6.3. Financial Overview

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. bioMerieux SA

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. Financial Overview

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. Ortho Clinical Diagnostics

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. Financial Overview

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. Thermo Fisher Scientific, Inc.

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Product Portfolio

            14.3.9.3. Financial Overview

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

        14.3.10. F. Hoffmann-La Roche AG

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Product Portfolio

            14.3.10.3. Financial Overview

            14.3.10.4. SWOT Analysis

            14.3.10.5. Strategic Overview

        14.3.11. Merck KGaA

            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.11.2. Product Portfolio

            14.3.11.3. Financial Overview

            14.3.11.4. SWOT Analysis

            14.3.11.5. Strategic Overview

        14.3.12. Agilent Technologies, Inc.

            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.12.2. Product Portfolio

            14.3.12.3. Financial Overview

            14.3.12.4. SWOT Analysis

            14.3.12.5. Strategic Overview

        14.3.13. Waters Corporation

            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.13.2. Product Portfolio

            14.3.13.3. Financial Overview

            14.3.13.4. SWOT Analysis

            14.3.13.5. Strategic Overview

List of Table

Table 01: Global Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Life Science Reagents Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 03: Global Life Science Reagents Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Life Science Reagents Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 06: North America Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Europe Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Europe Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 10: Asia Pacific Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 12: Asia Pacific Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Latin America Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Latin America Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Middle East & Africa Life Science Reagents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa Life Science Reagents Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 18: Middle East & Africa Life Science Reagents Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Life Science Reagents Market Size (US$ Mn) Forecast, 2017–2031

Figure 02: Global Life Science Reagents Market Value Share, by Product, 2021

Figure 03: Global Life Science Reagents Market Value Share, by End-user, 2021

Figure 04: Global Life Science Reagents Market Value Share, by Region, 2021

Figure 05: Global Life Science Reagents Market Value Share Analysis (US$ Mn), by Product, 2021 and 2031

Figure 06: Global Life Science Reagents Market Attractiveness Analysis, by Product, 2022–2031

Figure 07: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chromatography Reagents, 2017–2031

Figure 08: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Molecular Diagnostics Reagents, 2017–2031

Figure 09: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Immunoassay Reagents, 2017–2031

Figure 10: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Clinical Chemistry Reagents, 2017–2031

Figure 11: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Cytometry Reagents, 2017–2031

Figure 12: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cell & Tissue Culture Reagents, 2017–2031

Figure 13: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology & Hemostasis Reagents, 2017–2031

Figure 14: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microbiology Reagents, 2017–2031

Figure 15: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 16: Global Life Science Reagents Market Value Share Analysis (US$ Mn), by End-user, 2021 and 2031

Figure 17: Global Life Science Reagents Market Attractiveness Analysis, by End-user, 2022–2031

Figure 18: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Diagnostics Laboratories, 2017–2031

Figure 19: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Commercial & Contract Research Manufacturers, 2017–2031

Figure 20: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic & Research Institutes, 2017–2031

Figure 21: Global Life Science Reagents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 22: Global Life Science Reagents Market Value Share Analysis, by Region, 2021 and 2031

Figure 23: Global Life Science Reagents Market Attractiveness Analysis, by Region, 2022–2031

Figure 24: North America Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

Figure 25: North America Life Science Reagents Market Value Share Analysis (US$ Mn), by Country, 2021 and 2031

Figure 26: North America Life Science Reagents Market Attractiveness Analysis, by Country, 2022–2031

Figure 27: North America Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031

Figure 28: North America Life Science Reagents Market Value Share Analysis, by End-user, 2021and 2031

Figure 29: North America Life Science Reagents Market Attractiveness Analysis, by Product, 2022–2031

Figure 30: North America Life Science Reagents Market Attractiveness Analysis, by End-user, 2022–2031

Figure 31: Europe Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

Figure 32: Europe Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031

Figure 33: Europe Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 34: Europe Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031

Figure 35: Europe Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031

Figure 36: Europe Life Science Reagents Market Attractiveness Analysis, by Product, 2022–2031

Figure 37: Europe Life Science Reagents Market Attractiveness Analysis, by End-user, 2022–2031

Figure 38: Asia Pacific Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

Figure 39: Asia Pacific Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031

Figure 40: Asia Pacific Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 41: Asia Pacific Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031

Figure 42: Asia Pacific Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031

Figure 43: Asia Pacific Life Science Reagents Market Attractiveness Analysis, by Product, 2022–2031

Figure 44: Asia Pacific Life Science Reagents Market Attractiveness Analysis, by End-user, 2022–2031

Figure 45: Latin America Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

Figure 46: Latin America Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031

Figure 47: Latin America Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 48: Latin America Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031

Figure 49: Latin America Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031

Figure 50: Latin America Life Science Reagents Market Attractiveness Analysis, by Product, 2022–2031

Figure 51: Latin America Life Science Reagents Market Attractiveness Analysis, by End-user, 2022–2031

Figure 52: Middle East & Africa Life Science Reagents Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2031

Figure 53: Middle East & Africa Life Science Reagents Market Value Share Analysis (US$ Mn), by Country/Sub-region, 2021 and 2031

Figure 54: Middle East & Africa Life Science Reagents Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 55: Middle East & Africa Life Science Reagents Market Value Share Analysis, by Product, 2021 and 2031

Figure 56: Middle East & Africa Life Science Reagents Market Value Share Analysis, by End-user, 2021 and 2031

Figure 57: Middle East & Africa Life Science Reagents Market Attractiveness Analysis, by Product, 2022–2031

Figure 58: Middle East & Africa Life Science Reagents Market Attractiveness Analysis, by End-user, 2022–2031

Figure 59: Global Life Science Reagents Market Share Analysis, by Company (2021)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

602

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved